All settlements
UpcomingProof TBD
Novo Nordisk, Eli Lilly
Ozempic and Mounjaro GI Injury Lawsuits
Lawsuits allege Ozempic and Mounjaro caused serious gastrointestinal injuries. Cases are ongoing, with no nationwide settlement available.
Key facts
- Claim deadline
- TBD
- Potential payment
- Payment varies
- Proof requirement
- TBD
- Status
- Upcoming
Eligibility
Who may qualify?
Check the covered dates, products, locations, and other official terms before you file.
Case overview
What is the Novo Nordisk, Eli Lilly case about?
A major lawsuit is unfolding against the makers of GLP-1 receptor agonist drugs, with plaintiffs claiming that medications like Ozempic and Mounjaro led to serious gastrointestinal injuries. The alleged harms include gastroparesis, intestinal blockages, and severe, persistent vomiting. According to the lawsuit, the drug makers knew of these risks but failed to adequately warn patients and misrepresented how safe the medications actually were.
Settlement administrator and official sources
- Listing verificationLast checked Aug 6, 2026
